203 related articles for article (PubMed ID: 29474459)
1. Correction: Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
Palatnik A; Ye S; Kendziorski C; Iden M; Zigman JS; Hessner MJ; Rader JS
PLoS One; 2018; 13(2):e0193687. PubMed ID: 29474459
[TBL] [Abstract][Full Text] [Related]
2. Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
Matone A; Derlindati E; Marchetti L; Spigoni V; Dei Cas A; Montanini B; Ardigò D; Zavaroni I; Priami C; Bonadonna RC
PLoS One; 2019; 14(1):e0211394. PubMed ID: 30673781
[TBL] [Abstract][Full Text] [Related]
3. Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake.
PLOS ONE Staff
PLoS One; 2016; 11(5):e0155168. PubMed ID: 28886011
[TBL] [Abstract][Full Text] [Related]
4. Correction: Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells.
Shankar J; Nabi IR
PLoS One; 2015; 10(7):e0132759. PubMed ID: 26167914
[TBL] [Abstract][Full Text] [Related]
5. Correction: Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis.
PLOS ONE Staff
PLoS One; 2018; 13(9):e0204463. PubMed ID: 30222767
[TBL] [Abstract][Full Text] [Related]
6. Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
PLOS ONE Staff
PLoS One; 2018; 13(8):e0203174. PubMed ID: 30138452
[TBL] [Abstract][Full Text] [Related]
7. Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
Loi S; Michiels S; Baselga J; Bartlett JMS; Singhal SK; Sabine VS; Sims AH; Sahmoud T; Michael Dixon J; Piccart MJ; Sotiriou C
PLoS One; 2019; 14(4):e0216175. PubMed ID: 31013327
[TBL] [Abstract][Full Text] [Related]
8. Correction: Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
PLOS ONE Staff
PLoS One; 2017; 12(12):e0190661. PubMed ID: 29287125
[TBL] [Abstract][Full Text] [Related]
9. Correction: Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube.
Kito M; Maeda D; Kudo-Asabe Y; Sato N; Shih IM; Wang TL; Tanaka M; Terada Y; Goto A
PLoS One; 2016; 11(7):e0160136. PubMed ID: 27441663
[TBL] [Abstract][Full Text] [Related]
10. Correction: Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
PLOS ONE Staff
PLoS One; 2017; 12(2):e0172417. PubMed ID: 28192526
[TBL] [Abstract][Full Text] [Related]
11. Correction: Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
McKay J; Tenet V; Franceschi S; Chabrier A; Gheit T; Gaborieau V; McKay-Chopin S; Avogbe PH; Tommasino M; Ainouze M; Hasan U; Vaccarella S
PLoS One; 2017; 12(7):e0181285. PubMed ID: 28686670
[TBL] [Abstract][Full Text] [Related]
12. Correction: The tree balance signature of mass extinction is erased by continued evolution in clades of constrained size with trait-dependent speciation.
Yang GD; Agapow PM; Yedid G
PLoS One; 2018; 13(5):e0197191. PubMed ID: 29734368
[TBL] [Abstract][Full Text] [Related]
13. Correction: Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth.
McGee D; Smith A; Poncil S; Patterson A; Bernstein AI; Racicot K
PLoS One; 2018; 13(6):e0199566. PubMed ID: 29912991
[TBL] [Abstract][Full Text] [Related]
14. Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
PLOS ONE Staff
PLoS One; 2016; 11(12):e0168429. PubMed ID: 27936215
[TBL] [Abstract][Full Text] [Related]
15. Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(5):e0216968. PubMed ID: 31071170
[TBL] [Abstract][Full Text] [Related]
16. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
PLoS One; 2020; 15(5):e0233739. PubMed ID: 32437439
[TBL] [Abstract][Full Text] [Related]
17. Correction: Serum selenium levels and the risk of progression of laryngeal cancer.
Lubiński J; Marciniak W; Muszynska M; Jaworowska E; Sulikowski M; Jakubowska A; Kaczmarek K; Sukiennicki G; Falco M; Baszuk P; Mojsiewicz M; Kotsopoulos J; Sun P; Narod SA; Lubiński JA
PLoS One; 2018; 13(3):e0194469. PubMed ID: 29529076
[TBL] [Abstract][Full Text] [Related]
18. Correction: FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
Tiwary S; Xu L
PLoS One; 2017; 12(10):e0187388. PubMed ID: 29073284
[TBL] [Abstract][Full Text] [Related]
19. Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
PLOS ONE Staff
PLoS One; 2017; 12(11):e0188991. PubMed ID: 29186187
[TBL] [Abstract][Full Text] [Related]
20. Correction: Psychological Well-Being and the Human Conserved Transcriptional Response to Adversity.
Fredrickson BL; Grewen KM; Algoe SB; Firestine AM; Arevalo JM; Ma J; Cole SW
PLoS One; 2016; 11(6):e0157116. PubMed ID: 27257887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
